In 2023, Kangji Medical Holdings completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Kangji Medical Holdings has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020-2019 |
|---|---|---|---|---|
Total Scope 1 | 164.22a | 145.52a | 127.15b | |
Total Scope 2 | ||||
Unspecified Calculation Method | 3,756.49a | 3,325.5a | 2,585.21b | |
Total Scope 3 | N/A | N/A | N/A | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 1.2603a | 1.2885a | 1.1738b |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2023, the total operational greenhouse gas (GHG) emissions of Kangji Medical Holdings amounted to 3,920.71 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Kangji Medical Holdings increased by 12.96%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
In 2023, the total Scope 1 emissions of Kangji Medical Holdings were 164.22 metric tons of CO₂ equivalent (tCO₂e).a
Since 2021, Kangji Medical Holdings's Scope 1 emissions have increased by 29.15%, reflecting a rising long-term trend in Scope 1 emissions over time.ab
Compared to the previous year (2022), Kangji Medical Holdings's Scope 1 emissions increased by 12.85%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a
In 2023, Kangji Medical Holdings reported Scope 2 greenhouse gas (GHG) emissions of 3,756.49 tCO₂e without specifying the calculation method.a
Since 2021, Kangji Medical Holdings's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 45.31%, reflecting a rising long-term trend in Scope 2 emissions over time.ab
Compared to the previous year (2022), Kangji Medical Holdings's Scope 2 emissions (Unspecified Calculation Method) rose by 12.96% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energya
In 2023, Kangji Medical Holdings reported its Scope 2 emissions using an unspecified methodology.a
In 2023, Kangji Medical Holdings reported Scope 1 greenhouse gas (GHG) emissions of 164.22 tCO₂e and total revenues of USD 130 millions. This translates into an emissions intensity of 1.26 tCO₂e per millions USD.a
In 2023, Kangji Medical Holdings reported a Scope 1 emissions intensity of 1.26 tCO₂e per millions USD. Compared to the peer group median of 4.33, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
In 2023, Kangji Medical Holdings ranked 5 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places Kangji Medical Holdings among the top performers, with one of the lowest emissions intensities relative to peers.a